• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Prof Andrew Cope

Country: King's College London, United Kingdom

Andrew Cope graduated in Medicine from the University of London with First Class Honours. After training in general internal medicine at Northwick Park Hospital, The National Hospital for Nervous Diseases and the Royal Brompton Hospital, he trained in rheumatology with Professor Sir Ravinder Maini and Dr. Barbara Ansell CBE. In 1990, he was awarded a Wellcome Trust Clinical Training Fellowship, studying for a PhD in Cytokine Biology with Professor Sir Marc Feldmann at the Kennedy Institute of Rheumatology. Following a postdoctoral fellowship with Professor Hugh McDevitt at Stanford University, California, studying transgenic models of autoimmunity, he returned to the Kennedy Institute to set up his own laboratory supported by a Senior Wellcome Fellowship in Clinical Science. In 2005 Andrew Cope was appointed Reader in Molecular Medicine at the Kennedy Institute of Rheumatology, and in 2008 was recruited to the Arthritis Research UK Chair in Rheumatology at King’s College London. He is currently Head of the Centre for Rheumatic Diseases at King’s.

The Cope lab is housed in 1200m2 of dedicated research space in the Centre for Inflammation Biology and Cancer Immunology (CIBCI) on the Guy’s Campus, a Centre of the School of Immunology and Microbial Sciences. Research focuses on two key themes: defining aberrant pathways of T cell activation and differentiation in the context of chronic inflammatory diseases, such as rheumatoid arthritis; understanding how allelic variants of immunologically important genes contribute to autoimmune disease pathogenesis. His clinical research interests revolve around aspects of inflammatory arthritis, including very early inflammatory arthritis and disease remission states. He is the Chief Investigator of the RA prevention studies – the APIPPRA and ALTO trials. Prof Cope joined the Board of Trustees of the Kennedy Trust for Rheumatology Research in 2015, chairing the Trust’s Research Sub-Committee. In 2021, after being nominated by the British Society for Rheumatology, he was elected to the EULAR Research Committee, on which he chairs the Clinical Research Sub-Committee.

Share This Speaker

Key dates

More speakers

Eve Smith

Eve Smith

University of Liverpool, Alder Hey Children's NHS Foundation Trust, United Kingdom
Ernest Choy

Prof. Ernest Choy

Cardiff University School of Medicine, United Kingdom
Jamie Lim

Jamie Lim

Tan Tock Seng Hospital, Singapore
Muhammad Haroon

Muhammad Haroon

Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Pakistan

Prof. Lai-Shan Tam

The Chinese University Of Hong Kong, China
Raphaela Goldbach-Mansky

Raphaela Goldbach-Mansky

Niaid, National Institutes of Health (NIH), United States